Gamma-hydroxy butyric acid: Neurotransmitter, sedative and party drug;Gamma-hydroxybuttersäure: Neurotransmitter, sedativum und droge

Wiener Medizinische Wochenschrift

Volumn 155, Issue 13-14, 2005, Pages 315-322

  Meyer, Sascha ^a   Kleinschmidt, Stefan ^a   Gottschling, Sven ^a   Gortner, Ludwig ^a   Strittmatter, Matthias ^b  

^a SAARLAND UNIVERSITY   (Germany)

^b Klinikum Merzig   (Germany)

Author keywords

Alcohol withdrawal syndrome; Gamma hydroxybutyric acid; Intensive care medicine; Intoxication; Liquid ecstasy; Narcolepsy; Sedation

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; 4 AMINOBUTYRIC ACID; NEUROTRANSMITTER; OXYBATE SODIUM; SEDATIVE AGENT;

ALCOHOL WITHDRAWAL; CLINICAL PRACTICE; COMA; DEATH; DISEASE SEVERITY; DRUG ABUSE; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG ELIMINATION; DRUG INTOXICATION; DRUG METABOLISM; DRUG OVERDOSE; FIRST PASS EFFECT; HUMAN; INTENSIVE CARE UNIT; MAMMAL; NARCOLEPSY; RESPIRATION DEPRESSION; REVIEW; SEDATION;

ADULT; ANIMALS; BRAIN; CHILD; GAMMA-AMINOBUTYRIC ACID; HUMANS; HYDROXYBUTYRATES; HYPNOTICS AND SEDATIVES; INTENSIVE CARE; NEUROTRANSMITTER AGENTS; OVERDOSE; STREET DRUGS; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 23244449925     PISSN: 00435341     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10354-005-0174-4     Document Type: Review

References (59)

1. +. Presse Méd 50: 1867-1869
2. Kleinschmidt S, Schellhase C, Mertzlufft F (1999) Continuous sedation during spinal anesthesia: gamma-hydroxybutyrate vs. propofol. Eur J Anesthesiol 16: 23-30
3. Addolorato G, Catelli F, Stefanini GF, Casella G, Caputo F, Marsigli L, Bernardi M, Gasbarrini G (1996) An open multicentre study evaluating 4-hydroxybutyric acid sodium salt in the medium-term treatment of 179 alcohol dependent subjects. Alcohol Alcohol 31:341-345
4. Addolorato G, Balducci G, Capristo E, Attilia ML, Gasbarrini G, Ceccanti M (1999) Gamma-hydroxybutyric acid (GHB) in the treatment of alcohol withdrawal syndrome: a randomized comparative study versus benzodiazepine. Alcohol Clin Exp Res 23: 1596-1604
5. Ferrara SD, Zotti S, Tedeschi L, Frison G, Castagna F, Gessa GL, Palatini P (1992) Phamacokinetics of gamma-hydroxybutyric acid in alcohol dependent patients after single and repeated oral doses. Br J Pharmac 34: 231-235
6. Gallimberti L, Cibin M, Pagnin P, Sabbion R, Pani PP, Piratsu R, Ferrara SD, Gessa GL (1993) Gamma hydroxybutyric acid in the treatment of opiate withdrawal syndrome. Neuropsychopharmacology 9: 77-81
7. Gallimberti L, Ferri M, Ferrara SD, Fadda F, Gessa GL (1992) Gamma-hydroxybutyric acic in the treatment of alcohol dependence: a double blind study. Alcohol Clin Exp Res 16: 673-676
8. Gallimberti L, Canton G, Gentile N, Ferri M, Cibin M, Ferrara SD, Fadda SD, Gessa GL (1989) Gamma-hydroxybutyric acid for treatment of alcohol withdrawal syndrome. Lancet 2: 787-789
9. Lenzenhuber E, Müller C, Rommelspacher H, Spies C (1999) Gamma-Hydroxybuttersäure zur Therapie des Alkoholentzugssyndroms bei Intensivpatienten. Vergleich zweier symptomorientierter Konzepte. Anaesthesist 48: 89-96
10. Nimmerrichter AA, Walter H, Gutierrez-Lobos KE, Lesch OM (2002) Double-blind controlled trial of gamma-hydroxybutyrate and clomethiazole in the treatment of alcohol withdrawal. Alcohol Alcohol 37: 67-73
11. Mamelak M, Scharf MB, Woods M (1986) Treatment of narcolepsy with γ-hydroxybutyrate. A review of clinical sleep lab findings. Sleep 9: 285-289
12. Scrima L, Hartman P, Johnson H, Thomas E, Hiller F (1990) The effects of gamma-hydroxybutyrate on the sleep of narcolepsy patients: a double blind study. Sleep 13: 479-490
13. Scharf MB, Lai AA, Branigan B, Stover R, Berkovitz DB (1998) Pharmacokinetics of gammahydroxybutyrate (GHB) in narcoleptic patients. Sleep 21: 507-514
14. Laub A, Theurer G, Bodensohn M, Buerger U (1997/8) Sedation of children with gamma-hydroxybutyric acid for MRI examinations. Pädiat Prax 53: 687-692
15. Meyer S, Gottschling S, Georg T, Lothschütz D, Graf N, Sitzmann FC (2003) Gamma-hydroxbutyrate versus chlorprothixene/phenobarbital sedation in children undergoing MRI studies. Klin Padiatr 215: 69-73
16. Chin RL, Sporer KA, Cullison B (1998) Clinical course of gamma-hydroxybutyrate overdose. Ann Emerg Med 31: 716-722
17. Degenhardt L, Darke S, Dillon P (2003) The prevalence and correlates of gamma-hydroxybutyrate (GHB) overdose among Australian users. Addiction 98: 199-204
18. Dyer JE, Roth B, Hyma BA (2001) Gamma-hydroxybutyrate withdrawal syndrome. Ann Emerg Med 37: 147-153
19. Hahne N, Weinmann W, Nebel BW (2004) Intoxikation mit γ-Hydroxybutyrat. Anaesthesist 53: 950-954
20. Snead OC, Liu CC (1984) Gamma hydroxybutyric acid binding sites in rat and human brain synaptosomal membranes. Biochem Pharmacol 33: 2587-2890
21. Wong CG, Gibson, KM, Snead OC 3rd (2004) From the street to the brain: neurobiology of the recreational drug gamma-hydroxybutyric acid. Trends Pharmacol Sci 25: 29-34
22. Jensen K, Mody I (2001) GHB depresses fast excitatory and inhibitory synaptic transmission via GABAB receptors in mouse neocortical neurons. Cereb Cortex 11: 424-429
23. Maitre M (1997) The gamma-hydroxybutyrate signalling system in brain: organization and functional implications. Prog Neurobiol 51: 337-361
24. Snead O, Nichols AC, Liu CC (1992) Gamma hydroxybutyric acid binding sites: interaction with the GABA/benzodiazepine/picrotoxin receptor. Neurochem Res 17: 201-204
25. Vayer P, Mandel P, Maitre M (1987) Gamma-hydroxybutyrate, a possible neurotransmitter. Life Sci 41: 547-557
26. Kleinschmidt S, Mertzlufft F (1995) Gamma-Hydroxy-Buttersäure - Hat sie einen Stellenwert in Anästhesie und Intensivmedizin? Anaesthesiol Intensivmed Notfallmed Schmerztrier 30: 393-402
27. Vree TB, Damsma J, vam den Bogaert AG, van der Kleijn E (1978) Pharmacokinetics of 4-hydroxybutyrate in man, rhesus monkey and dogs. In: Frey R (Hrsg) Neuere Untersuchungen mit gamma-Hydroxybuttersäure. Anästhesiologie und Intensivmedizin, 110. Springer, Berlin Heidelberg New York, S. 21-28
28. Kleinschmidt S (2004) Analgesie, Sedierung, Relaxation und Therapie von Psychosyndromen. In: Burchardi H, Larsen R, Schuster H, Suter PM (Hrsg) Die Intensivmedizin, 9. Aufl. Springer, Berlin Heidelberg New York Tokyo, S 293-322
29. Soltész S, Silomon M, Biedler A, Kleinschmidt S, Benak J, Molter GP (2001) Gammahydroxybuttersäure-Ethanolamid (LK 544). Die Eignung von LK 544 zur Sedierung von Intensivpatienten im Vergleich mit Midazolam. Anaesthesist 50: 323-328
30. Tung A, Rosenthal A (1995) Patients requiring sedation. Crit Care Clin 11: 791-802
31. Pichlmeier R, Schneck HJ (1991) Gamma-Hydroxybuttersäure (GHB) als Basis-Sedativum in der Intensivmedizin. Intensiv Notfallbehandl 16: 106-112
32. Pospiech R, Schmidt E (1993) Zum Einsatz von Gamma- Hydroxybuttersäure (GHB) bei langzeitbeatmeten internistischen Intensivpatienten. Intensiv Notfallbeh 18: 157-164
33. Henderson RS, Holmes C (1976) Reversal of the anaesthetic action of sodium gamma hydroxybutyrate. Anaesth Intens Care 4: 352-354
34. Mamelak M (1989) Gamma-hydroxybutyrate: an endogenous regulator of energy metabolism. Neurosci Biobehav Rev 13: 187-198
35. Strong AJ, Howd A, Hunt JM (1983) Reduction of increased intracranial pressure (ICP) by gamma-hydroxybutyrate following severe head injury. Br J Surg 70: 303
36. Strong AJ (1984) Gamma hydroxybutyric acid and intracranial pressure. Lancet 1: 1304
37. Escuret E, Baldy-Moulinier M, Roquefeuil B, Freebeau P (1979) Gamma hydroxybutyrate as a substitute for barbiturate therapy in comatose patients with head injury. Acta Neurol Scand 72: 38-39
38. Planegger C (1990) Effect of gammahydroxybutyrate on intracranial pressure, mean systemic arterial pressure and cerebral perfusion pressure in experimentally induced brain oedema of the rat. Zentralbl Neurochr 51: 24-33
39. Yosunkaya A, Ak A, Bariskaner H, Üstün ME, Tuncer S, Gürbilek M (2004) Effect of gamma-hydroxybutyric acid on lipid peroxidation and tissue lactate level in experimental head trauma. J Trauma 56: 585-590
40. Yosunkaya A, Üstün ME, Bariskaner H, Tavlan A, Gürbilek M (2004) Effect of gamma-hydroxybutyric acid on tissue Na+,K+-ATPase levels after experimental head injury. Acta Anaesthesiol Scand 48: 631-636
41. Hunter AS, Long WJ, Ryrie CG (1971) An evaluation of gamma-hydroxybutyric acid in paediatric practice. Br J Anaesth 43: 620-628
42. Fadda F, Colombo G, Mosca E, Gessa G (1989) Suppression by gamma hydroxybutyric acid of ethanol withdrawal symptoms in rats. Alcohol Alcohol 24: 447-451
43. Beghe F, Carpanini MT (2000) Safety and tolerability of gamma-hydroxybutyric acid in the treatment of alcohol-dependent patients. Alcohol 20: 223-225
44. Fuller DE, Hornfeldt CS, Kelloway JS, Stahl PJ, Anderson TF (2004) The Xyrem risk management program. Drug Saf 27: 293-306
45. Borgen LA, Okerholm RA, Lai A, Scharf MB (2004) The pharmacokinetics of sodium oxybate oral solution following acute and chronic administration to narcoleptic patients. J Clin Pharmacol 44: 253-257
46. Nicholson KL, Balster RL (2001) GHB: a new and novel drug of abuse. Drug Alcohol Depend 63: 1-22
47. US Drug Enforcement Agency (2001) Drug Intelligence Brief-Club drugs: An update [www document]. DEA Intelligence division, Office of Domestic Intelligence, Domestic strategy Unit. URL www.usdoj.gov/dea/pubs/intel/01026/ index.html
48. Weir E (2000) Raves: a review of the culture, the drugs and the prevention of harm. CMAJ 162: 1843-1848
49. Mokhlesi B, Garimella P, Joffe A, Velho V (2004) Street drug abuse and critical illness, Int Care Med 30: 1526-1536
50. Steel IM, Ryan JM (1996) γ-hydroxybutyrate is a new recreational drug that may lead to loss of consciousness. BMJ 313: 424
51. Struwe FG, Hermanns-Clausen M (2002) Liquid ecstasy - eine wichtige Differentialdiagnose plötzlich einsetzender Bewusstlosigkeit bei jungen Patienten. Kinder- und Jugendmedizin 2: A78
52. European Monitoring Centre for Drugs and Drug Addiction (EMCDDA): Report on the risk assessment of GHB in the framework of the joint action on new synthetic drugs. Lissabon, 2001; http://www.dass.stir.ac.uk/DRUGS/Certificate/ Module2/Task4/ghb.pdf
53. Kam PCA, Yoong FFY (1998) Gamma-hydroxybutyric acid: an emerging recreational drug. Anaesthesia 53: 1195-1198
54. Galloway GP, Frederick SL, Staggers FE (1997) Gamma-hydroxybutyrate: an emerging drug of abuse that causes physical dependence. Addiction 92: 89-96
55. Jenkins DH (2000) Substance abuse and withdrawal in the intensive care unit. Contemporary issues. Surg Clin North Am 80: 1033-1053
56. Miotto K, Darakjian J, Basch J, Murray S, Zogg J, Rawson R (2001) Gamma-hydroxybutyric acid: patterns of use, effects and withdrawal. Am J Addict 10: 232-241
57. Friedman J, Westlake R, Furman M (1996) "Grievous bodily harm": Gamma hydroxybutyrate abuse leading to a Wernicke-Korsakoff syndrome. Neurology 46: 469-471
58. Ross M, Mattison AM, Franklin D (2003) Club drugs and sex on drugs are associated with different motivations for gay circuit party attendance in men. Subst Abuse Misabuse 38: 1173-1183
59. Varela M, Nogue S, Oros M, Miro O (2004) Gamma hydroxybutyrate use for sexual assault. Emerg Med 12: 255-256